On the surface it's the kind of thing the market doesn't want to see. In reality though, CollabRx Inc. (NASDAQ:CLRX) will be far better off - and far batter positioned to reward shareholders - by doing what needs to be done in order to continue capitalizing on the opportunity it has in front of it. And what exactly did CLRX do? It raised some money by shares it had sitting on the shelf.
All told, on Thursday, CollabRx put about $1.8 million in its pocket by issuing 913,500 shares at $2.00 apiece. That was a little less than Wednesday's closing price of $2.34, though as far as fund-raising goes within the small cap world, it wasn't anything unusual. Sometimes a company has to give newcomers a little incentive just to avoid dragging the process out for days while selling the new shares at the market price (doing so can cause far more damage to a stock's value than simply getting it all done in one shot the way CLRX did).
Top 5 Machinery Companies To Invest In Right Now: FuelCell Energy Inc.(FCEL)
FuelCell Energy, Inc., together with its subsidiaries, engages in the development, manufacturing, and sale of high temperature fuel cells for clean electric power generation primarily in South Korea, the United States, Germany, Canada, and Japan. The company offers proprietary carbonate Direct FuelCell Power Plants that electrochemically produce electricity from hydrocarbon fuels, such as natural gas and biogas. Its fuel cells operate on a range of hydrocarbon fuels, including natural gas, renewable biogas, propane, methanol, coal gas, and coal mine methane. The company also develops carbonate fuel cells, planar solid oxide fuel cell technology, and other fuel cell technologies. It provides its products to universities; manufacturers; mission critical institutions, such as correction facilities and government installations; hotels; and natural gas letdown stations, as well as to customers who use renewable biogas for fuel, including municipal water treatment facilities, br eweries, and food processors. The company was founded in 1969 and is headquartered in Danbury, Connecticut.
Advisors' Opinion:- [By Paul Ausick]
Another heavily traded Nasdaq stock today is FuelCell Energy Inc. (NASDAQ: FCEL). The fuel cell maker posted a new 52-week high today as it rides the coattails of Plug Power Inc. (NASDAQ: PLUG). Plug Power signed a deal with Wal-Mart Stores Inc. (NYSE: WMT) last week and has been on a tear ever since. FuelCell Energy�� shares are looking to close up 15.13% at $3.12 in a 52-week range of $0.84 to $3.40 (the new 52-week high). Share volume was about 13-times higher than the daily average of around 8 million shares traded.
- [By John Udovich]
Tesla Motors Inc (NASDAQ: TSLA) has a growing�battery fire mess on its hand but should investors in small cap fuel cell stock Plug Power Inc (NASDAQ: PLUG) be more worried than investors in fuel cell peers like FuelCell Energy Inc (NASDAQ: FCEL) and Ballard Power Systems Inc (NASDAQ: BLDP)? After all, Tesla Motors Inc�� battery fire problems seem to result from drivers running over debris that damage�or pierce the undercarriage rather than with the batteries�themselves (as in Boeing�� case). Nevertheless, any news about batteries or fuel cells and the like catching on fire could spill over�and impact peers - unless there are other concerns for investors. ��
Top 5 Small Cap Stocks To Invest In 2014: Achillion Pharmaceuticals Inc.(ACHN)
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.
Advisors' Opinion:- [By Keith Speights]
2. Achillion Pharmaceuticals (NASDAQ: ACHN )
Achillion recently experienced a delay in the game that it had hoped to play. The FDA placed a clinical hold on hepatitis C drug sovaprevir after patients in a phase 1 drug-drug interaction study with the drug combined with ritonavir-boosted atazanavir were found to have elevated liver enzyme levels. Shares dropped 25% in one day as a result. - [By Dan Carroll]
Few biotechs were hit as hard as Achillion Pharmaceuticals (NASDAQ: ACHN ) this week, however. Achillion makes up around 2% of the weight of the SPDR Biotech ETF, and its 7.5% loss this week was a major reason for the fund's fall. This stock has failed to capitalize on the markets' surge this year, losing 10% year-to-date. The company only recently named a new CEO, lifting its former R&D head and chief science officer to the top job. Achillion's still in the developmental stage of its life and thus produces no revenue, and the company's cash burn makes it seem likely that more share dilution is on its way as the company looks to advance its hepatitis-C pipeline over the coming years. Until Achillion produces some meaningful results from that pipeline, this stock will remain a risky play in an already risky space.
- [By Jon C. Ogg]
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) is getting destroyed on poor hep-C test results, and shares are down about 50%. Bank of America�Merrill Lynch downgraded it to Underperform from Buy after the news.
Top 5 Small Cap Stocks To Invest In 2014: Panera Bread Company(PNRA)
Panera Bread Company, together with its subsidiaries, owns, operates, and franchises retail bakery-cafes in the United States and Canada. Its bakery-cafes offer fresh baked goods, sandwiches, soups, salads, custom roasted coffees, and other complementary products, as well as provide catering services. The company also manufactures and supplies dough and other products to company-owned and franchise-operated bakery-cafes. As of March 29, 2011, it owned and franchised 1,467 bakery-cafes under the Panera Bread, Saint Louis Bread Co., and Paradise Bakery & Cafe names. The company was founded in 1981 and is based in St. Louis, Missouri.
Advisors' Opinion:- [By Demitrios Kalogeropoulos]
You could argue that Chipotle has even more reason to raise prices now. Food costs ticked up again this past quarter, to 33.1% of sales. Those rising costs bit into restaurant margins, cleaving almost two percentage points from profits. Chipotle's expenses are well above fast-casual rivals like Panera Bread (NASDAQ: PNRA ) , which books a steady 29% food charge. For its part, Panera hasn't shied away from pricing boosts. A 2.3% price rise helped the baker log a 3.3% jump in sales for the first quarter.
- [By Sean Williams]
This week, I want to highlight the co-CEOs of Panera Bread (NASDAQ: PNRA ) , Ronald Shaich (a co-founder of Panera Bread) and Bill Moreton, and point out why they've made such an incredible dynamic duo for shareholders, employees, and the community.
Top 5 Small Cap Stocks To Invest In 2014: Texas Instruments Incorporated(TXN)
Texas Instruments Incorporated engages in the design and sale of semiconductors to electronics designers and manufacturers worldwide. The company?s Analog segment offers high-performance analog products comprising standard analog semiconductors, such as amplifiers, data converters, and interface semiconductors; high-volume analog and logic products; and power management semiconductors and line-powered systems. Its Embedded Processing segment includes DSPs that perform mathematical computations to process and enhance digital data; and microcontrollers, which are designed to control a set of specific tasks for electronic equipment. The company?s Wireless segment designs, manufactures, and sells application processors and connectivity products. Its Other segment offers smaller semiconductor products, which include DLP products that are primarily used in projectors to create high-definition images; and application-specific integrated circuits. This segment also provides handhe ld graphing and scientific calculators, as well as licenses technologies to other electronic companies. The company serves the communications, computing, industrial, consumer electronics, automotive, and education sectors. Texas Instruments Incorporated sells its products through a direct sales force, distributors, and third-party sales representatives. It has collaboration agreements with PLX Technology Inc.; Neonode, Inc.; and Ubiquisys Ltd. The company was founded in 1938 and is headquartered in Dallas, Texas.
Advisors' Opinion:- [By Chuck Saletta]
What's working well with dividends?
The highlight of last week was Texas Instruments (NASDAQ: TXN ) paying out its $0.28-per-share dividend, which was an $0.08 increase over its previous dividend -- and a raise after only two quarters. The semiconductor giant has been under siege lately as it shuts down its mobile business because of increased competition. That increase was a welcome reminder that the company's business lines extend far beyond just the hot technology gadgets of the day and that its core operations still remain solid. - [By Dan Caplinger]
Texas Instruments (NASDAQ: TXN ) will release its quarterly report on Monday, and investors have been happy about the company's new strategy, sending the stock to its best levels since the tech boom in 2000. Yet the shrewdness of TI's strategy is that rather than going head-to-head against giants Intel (NASDAQ: INTC ) and Qualcomm (NASDAQ: QCOM ) , Texas Instruments has instead chosen to concentrate on its areas of greatest strength, ceding more competitive business to its rivals rather than fighting it out in a destructive price war.
No comments:
Post a Comment